Nse tips, mcx tips, ncdex tips ,stock futer tips ,options trading tips brokers advisors i 1st Earn after pay
Friday, 24 March 2017
sunpharma news
Sun Pharmaceutical Industries Ltd SUN.NS
* Says validation of regulatory filing of tildrakizumab with the european medicines agency (EMA) by Almirall.
* Tildrakizumab is an investigational IL-23P19 inhibitor being evaluated for the treatment of moderate-to-severe plaque psoriasis.
* Filing includes efficacy, safety data from pivotal phase III clinical trials that included over 1,800 patients Source text - Further company coverage: SUN.NS
Followers
Option tips
buy bank nifty 49200 ce @90 target 300/400
-
buy bank nifty@49200 sl 49000 target 49400/49600/49800 Recommendation: Buy Bank Nifty @ 49,200 Stop Loss (SL): 49,000 Targets: 1st Target: ...
-
Buy Bharathi airtel @1595 sl 1560 target 1630/1660
-
At Chandausi market , Mentha Oil is trading lower at Rs. 1025 per Kg, lower by 0.49 per cent from previous trading day. Mentha DMO is offere...